Client Charter

We are devoted to strengthening emerging pharmaceutical markets. To this end, we commit to upholding essential principles in all of our dealings with clients. Our Client Charter is our promise to you that ...

Tag Archives: Turkey

As biotech companies in emerging markets move from imitation to innovation, they will reach a decision point – focus on local health demands or develop medicines for industrialized countries with larger markets. The authors suggest that biotech companies can meet both demands through an entrepreneurial model. However. the logic of the entrepreneurial model is such […]

Pharmaceutical companies in Turkey face considerable challenges in 2010. From being one of the most prosperous markets in Central and Eastern Europe (CEE), short-term market performance is due to be substantially impaired by pricing and reimbursement revisions. Nevertheless, longer-term dynamics remain positive for drugmakers. This is reflected in the Business Environment Ratings for Q210, where […]